Emergency department visits for cannabis use are associated with an increased risk for a subsequent healthcare visit for an anxiety disorder, data suggested.
Newly released documents show that the FDA has determined that cannabis has legitimate medical use and that it should be moved from Schedule I to Schedule III on the controlled substances list.